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a,b,c,d Saudi ArabiaObjectives: Metabolic syndrome (MetS) is a group of multiple cardiovascular risk factors, including dysglycemia,
central obesity, high cholesterol, and hypertension. Cardiovascular disease is one of the most common complications of
MetS. Recent studies showed that prevalence of MetS among patients admitted with acute coronary syndrome was as
high as 46%.
Design: We conducted a cross-sectional study of 203 patients at the two main hospitals in Ta’if, Saudi Arabia.
Patients older than 18 years who were admitted to the Cardiac Care Unit (CCU) between the months of August
2013 and June 2014 were asked to participate. MetS diagnosis was made based on the International Diabetes Feder-
ation definition.
Results: A total of 203 patients participated, with 59.1% male and 40.9% were female. The mean age was 60.9 years
with a mean body mass index of 28.97 kg/m2 and a mean waist circumference of 95.45 cm. The prevalence of MetS
was 47.8%, primarily among obese female patients who reported sedentary lifestyles. Additionally, MetS patients
were more likely to be admitted with heart failure (p < 0.05) and more likely to have moderate-to-severe left-
ventricular hypertrophy (LVH; p < 0.05) relative to non-MetS patients.
Conclusion: Of the patients admitted to the CCU, 47.8% had MetS, with those patients likely to be female and
obese. Furthermore, MetS patients were more likely to be admitted with heart failure and suffer from moderate-
to-severe LVH.
 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Abbreviations
BMI body mass index
BP blood pressure
CCU Cardiac Care Unit
FBP fasting plasma glucose
HDL high-density lipoprotein
HF heart failure
IDF International Diabetes Federation
JNC 7 Joint National Committee on Prevention, Detec-
tion, Evaluation, and Treatment of High Blood
Pressure
LDL low-density lipoprotein
LVEF left-ventricle ejection fraction
LVH left-ventricular hypertrophy
MetS metabolic syndrome
NCEP-ATP III National Cholesterol Education Program-
Adult Treatment Panel III
NSTEMI non-ST-segment elevation myocardial infarction
RACE Registry of Acute Coronary Events
STEMI ST-segment elevation myocardial infarction
TG triglyceride
UA unstable angina
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METABOLIC SYNDROME PATIENTS IN CARDIAC CARE UNITSIntroduction
Metabolic syndrome (MetS) represents a clus-ter of dangerous cardiovascular risk fac-
tors, including central abdominal obesity, high
cholesterol, dysglycemia, and high blood pressure
[1–3]. The complications of MetS are broad, with
cardiovascular complications being the most com-
mon, especially coronary artery disease, heart fail-
ure, ischemic stroke [4], atrial fibrillation [5], and
aortic stenosis [6].
The estimated prevalence of MetS in patients
with acute coronary syndrome is high. The Gulf
Registry of Acute Coronary Events (Gulf RACE)
prospectively enrolled 6071 patients with acute
coronary syndrome from 65 centers in six adjacent
Middle Eastern gulf countries over a 6-month per-
iod. They diagnosed MetS based on guidelines
from the International Diabetes Federation (IDF)
Task Force on Epidemiology and Prevention,
American Heart Association, National Heart,
Lung, and Blood Institute, International
Atherosclerosis Society, World Heart Federation,
and the International Association for the Study
of Obesity. There were 3108 (46%) out of the
6701 patients with MetS, and they were more
likely to present with a non-ST segment elevation
myocardial infarction (NSTEMI; 37% vs. 28%) and
unstable angina (UA; 33% vs. 25%) as compared to
ST segment elevation myocardial infarction
(STEMI; 30% vs. 47%; all p < 0.001) [7].
In another study, Agoston-Coldea et al. [8] per-
formed a cross-sectional study in 256 patients with
acute coronary syndrome. The prevalence of MetS
was 47.26% as assessed by the criteria of the
National Cholesterol Education Program-Adult
Treatment Panel III (NCEP-ATP III). The cardio-
vascular risk has been correlated to MetS (OR
1.29; 95% CI, 1.05–1.54, p = 0.047) [8].
MetS is common in patients who are admitted
to the CCU, and those people are at risk of devel-
oping other cardiovascular complications, such as
ischemic heart disease. However, there are few
studies that identify the size and impact of the
problem in other patients, such as those with
heart failure and arrhythmia. The objective of
this study was to identify the prevalence and
clinical characteristics of MetS in CCU patients
in two of the major hospitals in Ta’if, whether
presenting with acute coronary syndrome or
other cardiac problems, using the new IDF defini-
tions of MetS.Materials and methods
A cross-sectional study was conducted at the
Division of Endocrinology and Cardiology at King
Abdulaziz Specialist Hospital and King Faisal
Hospital, Ta’if, Saudi Arabia. A total of 203
patients were admitted to the CCU between
August 2013 and July 2014, and those older than
18 years participated in the study. We excluded
unconscious patients. Detailed medical history,
including presenting illness, past medical history,
drug history, family history, special habits, and
physical activity, was obtained from participating
physicians directly from the patients after obtain-
ing their consent. Anthropometric measurements,
including height, weight, body mass index (BMI),
waist circumference, and hip circumference, were
measured.
The World Health Organization (WHO) recom-
mendations on physical activity for health [9] were
considered, which recommends adult do at least:
150 min of moderate-intensity physical activity or
75 min of vigorous-intensity physical activity or
an equivalent combination of moderate- and
vigorous-intensity activity.
Physical activity among patients was catego-
rized according to these recommendations into
healthy physical activity (for those who meet the
recommendations), non-healthy physical activity
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physically inactive).
Height and weight were measured while stand-
ing after removing shoes and heavy clothing and
looking straight ahead with shoulders relaxed,
arms at sides, back as straight as possible, legs
straight, feet flat, and heels close together. The
height was measured up to the top of the head
in centimeters (cm), and the weight was measured
in kilograms (kg). BMI was calculated and catego-
rized according to the WHO classification into
underweight (<18.5 kg/m2), healthy weight (18.5–
24.9 kg/m2), overweight (25–29.9 kg/m2), and obese
(P30 kg/m2) [10].
The waist circumference was measured accord-
ing to WHO STEPwise approach to surveillance
protocol that states that the measurement should
be made at the approximate midpoint between
the lower margin of the last palpable rib and the
top of the iliac crest [11]. According to the guideli-
nes of the Joint National Committee on Prevention,
Detection, Evaluation, and Treatment of High
Blood Pressure (JNC 7), the blood pressure was
measured while the patient was seated quietly for
at least 5 min in a chair [12]. At least two measure-
ments were made and the average was recorded.
Laboratory investigations, including fasting
blood glucose, random blood glucose, triglyceride,
high-density lipoprotein (HDL), low-density
lipoprotein (LDL), total cholesterol, and HbA1c
were measured. The cardiovascular markers were
measured daily and the peak troponin levels were
recorded. A board certified cardiologist performed
cardiac echocardiogram tests with a Philips iE33
ultrasound machine (Philips, Amsterdam, The
Netherlands), and the left-ventricle ejection frac-
tion (LVEF) and the left-ventricle hypertrophy
(LVH) were documented.
The definition of MetS was based on the new
IDF definition [13]. Patients with MetS must have
central obesity (defined as waist circumference
P94 cm for European males and P80 cm for
females; there were also ethnicity-specific values
for other groups), as well as any two of the follow-
ing four minor factors: (1) raised TG level:
P150 mg/dL (1.7 mmol/L) or specific treatment
for this lipid abnormality; (2) reduced HDL choles-
terol: <40 mg/dL (1.03 mmol/L) in males and
<50 mg/dL (1.29 mmol/L) in females or specific
treatment for this lipid abnormality; (3) systolic
BPP 130 mmHg or diastolic BPP 85 mmHg or
treatment of previously diagnosed hypertension;
and (4) raised fasting plasma glucose (FPG)
P100 mg/dL (5.6 mmol/L) or previously diag-
nosed with type 2 diabetes mellitus.The Institutional Review Board approval was
completed at King Abdulaziz Specialist Hospital
and King Faisal Hospital. All qualitative and
quantitative data were entered in Microsoft Excel
(Microsoft, Redmond, WA, USA) and analyzed
with SPSS software version 16 (SPSS Inc., Chi-
cago, IL, USA). The mean and standard deviation
(SD) were calculated. The clinical characteristics
were compared for patients with and without
MetS, and we defined statistical significance as
p < 0.05. Chi-square tests were performed for cat-
egorical variables and unpaired t tests for continu-
ous variables. The prevalence of each MetS
criteria was calculated and compared to the non-
MetS patients.Results
From August 2013 to July 2014, 203 patients were
admitted to the CCU and agreed to participate in
the study. There were 120 (59.1%) men and 83
(40.9%) women, with a mean age of 60.9 years
(SD, 14.4 years), mean BMI of 28.97 kg/m2 (SD,
5.4 kg/m2), mean waist circumference of 95.45 cm
(SD, 18.6 cm), and mean waist-to-hip ratio of 1.00
(SD, 0.1). We found that 53.7% had type 2 diabetes,
41.4% reported a sedentary lifestyle, and 14.8%
were smokers.
The percentage of overweight or obese patients
was 80.8%. The overall admission diagnosis was
26.1% with unstable angina (UA), 21.7% with heart
failure (HF), 18.2% with non-ST elevation MI
(NSTEMI), 16.3% with ST elevation MI (STEMI),
7.4% with arrhythmia, and 10.3% with other car-
diac diagnosis (Table 1).
Overall, 47.8% of the adult patients who were
admitted to the CCU met the diagnostic criteria
for MetS, with 12 (12.4%) having all four minor cri-
teria, 43 (44.3%) with three, and 42 (43.3%) with at
least two (Fig. 1). The most common criterion after
central obesity was high fasting blood sugar or
previously diagnosed type 2 diabetes, with 87
(89.7%) of patients with MetS having this criterion.
Versus non-MetS patients, those with MetS
were more likely to be a woman (60% vs. 40%,
p < 0.05), older (62.5 years vs. 59.4 years, p = 0.12),
diabetic (68% vs. 40%, p < 0.05), overweight/obese
(98% vs. 65%, p < 0.05), have a higher waist cir-
cumference (106 cm vs. 84.6 cm, p < 0.05), report
having a more sedentary lifestyle (48.5% vs.
34.9%, p < 0.05), have a higher HbA1c (8.3% vs.
7.1%, p < 0.05), and triglyceride level (129.4 mg/dL
vs. 120.7 mg/dL, p = 0.37; Table 3). Interestingly,
patients with MetS in this study had lower LDL











Table 1. Baseline characteristics.
Baseline characteristics Total sample, male and female
n %
Middle East (Arab) populations 188 92.6
Mean age, (y; mean ± SD) 60.9 ± 14.4
BMI (kg/m2) 28.97 ± 5.39
Waist circumference (cm) 95.45 ± 18.6
Waist-to-hip ratio 1.001 ± 0.103
Smoking
Active smokers 30 14.8




Sedentary lifestyle 84 41.4
<150 min of moderate- or <75 min of vigorous-activity
or a combination of both/wk
71 35
>150 min of moderate- or >75 min of vigorous-activity
or combination of both/wk
48 23.6
Chronic diseases
Diabetes mellitus, type 2 109 53.7
Using Metformin 67 33
Using Sulfonylurea 50 24.6
Hypertension 132 65.02
Using ACEI/ARB 84 41.4
BMI, kg/m2
18.5–24.9 (normal weight) 36 17.7
25.0–29.9 (overweight) 82 40.4
P30.0 (obese) 82 40.4
Admission diagnosis
Unstable angina 53 26.1




Other cardiac diagnosis 21 10.3
Metabolic syndrome 97 47.8
Total 203 100
ACEI/ARB = angiotensin-converting enzyme inhibitor/angiotensin receptor blocker; BMI = body mass index; NSTEMI = Non-ST-segment elevation
myocardial infarction; SD = standard deviation; STEMI = ST-segment elevation myocardial infarction.
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p < 0.05).
HF was the most common admission diagnosis
among the MetS group, with a prevalence of
28.9% versus 15.1% in the non-MetS group
(p < 0.05), followed by UA, with a prevalence of
27.8% versus 24.5% (p = 0.6) and NSTEMI 18.5%
versus 17.9% (p = 0.9; Fig. 2). STEMI was more
common in the non-MetS group relative to the
MetS group, with a prevalence of 18.9% versus
13.4% (p = 0.27), respectively, as well as arrhyth-
mia (10.4% vs. 4.1%, p = 0.1).
Cardiac echocardiogram showed that patients
with MetS were more likely to have moderate-
to-severe LVH (41.2% vs. 6.5%, p < 0.05) and lower
LVEH (33.9% vs. 39.8%, p = 0.24; Figs. 3 and 4).Interestingly, MetS patients tended to have lower
Troponin T (1.23 lg/L vs. 37.4 lg/L, p = 0.31).
According to IDF MetS criteria, a higher per-
centage of MetS patients had elevated waist cir-
cumference values relative to normal patients
(100% vs. 29.5%, p < 0.05). The MetS patients were
more likely to have a high fasting blood sugar
(89.7% vs. 53%, p < 0.05), low HDL (84.5% vs.
58.8%, p < 0.05), high BP (40% vs. 35.8%, p < 0.05),
high TG (30% vs. 22%, p = 0.18; Table 4).
A higher percentage of MetS patients were
women, with the most common diagnosis being
UA (30.1%) and HF (26.5%) as compared to men
with MetS, who presented more with UA
(23.3%), STEMI (22.5%), and NSTEMI (19.2%).









Table 2. Analysis of baseline characteristics based on gender.
Sociodemographic characteristics Male Female p
n (W%) n (W%)
Eastern Mediterranean & Middle
East (Arab) populations
110 58.5 78 41.5 0.79
Smoking
Active smokers 30 25 0 0 <0.05
2nd-hand smoker 6 5 10 12.05%
Former 34 28.3 0 0
Never 50 41.7 73 87.95%
Physical activity (min/wk)
Sedentary lifestyle 36 30 48 57.8% <0.05
<150 43 35.8 28 33.7%
>150 41 34.2 7 8.5
Chronic disease
Diabetes mellitus, type 2 55 45.8 54 65.1% 0.003
Using Metformin 35 29.2 32 38.6% 0.16
Using Sulfonylurea 26 21.7 24 28.9% 0.46
Hypertension 63 52.5 69 83.1% <0.05
Using ACEI/ARB 34 28.3 50 60.2% <0.05
BMI (kg/m2)
18.5–24.9 (normal weight) 23 19.2 13 15.7% 0.04
25.0–29.9 (overweight) 54 45 28 33.7%
P30.0 (obese) 41 34.2 41 33.7%
Admission diagnosis
Unstable angina 28 23.3 25 30.1 0.03
Heart failure 22 18.3 22 26.5
NSTEMI 23 19.2 14 16.9
STEMI 27 22.5 6 7.2
Arrhythmia 8 6.7 7 8.4
Other cardiac diagnosis 12 10 9 10.8
Metabolic syndrome 47 39.2 50 60.2 0.003
Mean Mean
Age (y) 58.38 64.55 0.002
BMI 28.1 30.2 0.007
Waist circumference (cm) 94.5 96.8 0.39
Waist-to-hip ratio 1.01 0.97 0.004
Total 120 59.1 83 40.9
ACEI/ARB = angiotensin-converting enzyme inhibitor/angiotensin receptor blocker; BMI = body mass index; NSTEMI = Non-ST-segment elevation














Figure 1. Distributions of the patient sample based on the number of minor factors present. MetS = metabolic syndrome.
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Table 3. Analysis according to presence and absence of MetS.
Baseline characteristics MetS group Non-MetS group p
Mean age (y) 62.5 59.4 0.12
Female, n (%) 50 (60.2) 33 (39.8) 0.003
Male, n (%) 47 (39.2) 73 (60.8)
Mean BMI (kg/m2) 31.8 26.4 <0.05
Overweight or obese (%) 97.9 65% <0.05
Mean waist circumference (cm) 106.4 84.6 <0.05
Sedentary lifestyle (%) 48.5 34.9 <0.05
Active smoker (%) 5.1 23.4 <0.05
Diabetes mellitus, type 2 (%) 68 40.6 <0.05
Blood pressure
Systolic 138.4 130.2 0.07
Diastolic 75.8 76.3 0.8
Laboratory results (mg/dL)
Total cholesterol 141.9 151.3 0.17
Low-density lipoprotein 84.8 96 0.04
High-density lipoprotein 35.44 37.05 0.41
Triglyceride 129.43 120.67 0.37
Fasting blood sugar 174.7 130.8 <0.05
HbA1c 8.3 7.1 <0.05
Troponin T (mean lg/L) 0.52 37.4 0.31
Cardiac echocardiogram (%)
Ejection fraction 33.9 39.8 0.24
Mild LVH 29.4 56.3 <0.05
Moderate-to-severe LVH 41.2 6.3 <0.05








Mild LVH *Mod-Sever LVH EF
MetS
non-MetS
Figure 3. Cardiac echocardiogram results among patients with MetS versus non-MetS patients. *Significant p. EF = ejection fraction; LVH = left-









HF UA NSTEMI STEMI Arrhthmia
MetS
non-MetS
Figure 2. The diagnosis on admission to the cardiac care unit according to the presence or absence of MetS. HF = heart failure; MetS = metabolic
syndrome; NSTEMI = Non-ST-segment elevation myocardial infarction; STEMI = ST-segment elevation myocardial infarction.
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Figure 4. The association of LVH with MetS and HTN. HTN = hypertension; LVH = left-ventricular hypertrophy; MetS = metabolic syndrome.
Table 4. The prevalence of MetS criteria among the MetS group as compared to the non-MetS group.
MetS criteria MetS group Non-MetS group p
Elevated waist circumference (males >94 cm; females >80 cm) 97 (100) 31 (29.5) <0.05
High fasting blood sugar (100 mg/dL or diagnosed as diabetic/in treatment) 87 (89.7) 56 (52.8) <0.05
Low HDL (males <40 mg/dL; females <50 mg/dL; or in treatment) 82 (84.5) 62 (58.5) <0.05
High blood pressure (>130/85 mmHg or in treatment) 62 (39.9) 38 (35.8) <0.05
High triglyceride (>150 mg/dL or in treatment) 29 (29.9) 23 (21.7) 0.18
Data are presented as n (%).
HDL = high-density lipoprotein; MetS = metabolic syndrome.
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(64.5 years vs. 58.3 years), mean BMI (30 vs. 28.1),
obesity likelihood (49.4% vs. 34.2%), reports of
sedentary lifestyle (57.8% vs. 30%), and were more
likely to have type 2 diabetes (65.1% vs. 45.8%),
and hypertension (83.1% vs. 52.5%; Table 2).Discussion
Our study indicated high rates of MetS across all
segments of patients in the CCU and was not lim-
ited to patients with acute coronary syndrome.
Our findings showed that women who were
admitted to the CCU were more likely to have
MetS. MetS patients were also more likely to be
obese and physically inactive. Furthermore, we
found a strong association between MetS and
moderate-to-severe LVH and LVEH. Although
the majority of patients in the MetS group, as well
as non-MetS patients, had LVH and were also
known to be hypertensive as compared to the
MetS group, the non-MetS group was more likely
to have mild LVH. In our study, hypertension
increased the risk of LVH, while MetS may
increase the severity of the LVH.
None of the previous studies used the new IDF
definition for MetS diagnosis, which included
the history of specific treatment for lipid abnor-
mality, history of diabetes, and hypertension as
criteria. This could be better based on the variabil-
ity that may occur in FPG and BP due to acute
metabolic stress related to myocardial infarctionor the effect of medications the patient might
use [14].
The prevalence of MetS in our study was similar
to that reported in 2008 by Agoston-Coldea et al.
[8] and those in the 2010 Gulf RACE study [7,8]
Our study was similar to Agoston-Coldea et al.
[8], except that they included patients with acute
coronary syndrome only, and the MetS diagnosis
was based on NCEP-ATP III criteria. Our study
included all cardiac patients admitted to the
CCU, either with or without acute coronary syn-
drome, and we used population-specific criteria
for MetS diagnosis.
Generally, the baseline characteristics of the
CCU patients showed that they were older, more
likely to be diabetic, and have a higher BMI, waist
circumference, and waist-to-hip ratio. Addition-
ally >66% of patients reported having a sedentary
lifestyle, and 25% had UA and then HF.
The relationship between MetS and HF has
been studied. In a cohort study, Butler et al. [15]
studied the impact of MetS on cardiovascular
events in 3035 older adults with a 6-year follow
up, finding that HF hospitalization was more com-
mon in MetS patients as compared to non-MetS
patients (10% vs. 6.1%, p < 0.001) [15]. In our study,
HF was the most common admission diagnosis in
MetS patients as compared to non-MetS patients
(28.9% vs. 15.1%, p < 0.05).
Women in the CCU were more likely to be pas-
sive smokers, diabetic, obese, hypertensive, and
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METABOLIC SYNDROME PATIENTS IN CARDIAC CARE UNITSactive or former smokers than women, and more
likely to present with STEMI and NSTEMI. All of
these risk factors may help explain the gender dif-
ference in the CCU presentation.
Non-MetS patients are more likely to be men,
elderly, active smokers, physically inactive, over-
weight, and diabetics, as well as tending to have
high cholesterol, LDL, and troponin T levels and
present with UA and STEMI.
Our study had some limitations. It is a cross-
sectional study, therefore, we were unable to
assess causality. additionally, some of the behav-
ioral data, such as smoking and physical activity,
was self-reported. Our strengths included evalua-
tion of all patients admitted to the CCU, and we
used Middle East population-specific criteria.
In the recent American Heart Association 2015
meeting, a paper was presented (oral presenta-
tion) studying 6000 patients with myocardial
infarction diagnosis, where 707 patients met diag-
nostic criteria of newly diagnosed diabetes, while
only 30% were immediately treated for diabetes.
After a 1-year follow up, those who were
untreated for the newly diagnosed diabetes were
1.5-fold more likely to experience major adverse
cardiac events as compared to those who were
treated. This emphasizes on the importance of
early diagnosis and treatment of major cardiac-
related risk factors, such as diabetes and MetS,
when cardiac patients are evaluated. More efforts
related to education and awareness should be
encouraged among healthcare providers who are
caring for those patients. Also, public health edu-
cation campaigns to educate high-risk populations
about MetS and its complications are important.
Providing comprehensive care that will address
both the admission of cardiac disease, as well as
its risk factors, is key to improve patient outcomes.
Larger studies to determine the size and impact
of MetS on cardiovascular incidence and compli-
cations, relationships between MetS and sex
hormones, and the impact of controlling
cardiovascular-related risk factors on CCU patient
outcomes in Saudi Arabia are needed.Conclusion
The prevalence of MetS among patients admit-
ted to the CCU based on the new IDF definitionwas 47.8%, and was more common among
females. MetS patients were more likely to be
overweight/obese and diabetic, and more likely
to be admitted with HF and suffer from
moderate-to-severe LVH.
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